Abstract: A master node (MN) can implement a method for managing a conditional procedure that involves a user equipment (UE), a candidate secondary node (C-SN), and the MN. The method may include transmitting, to the C-SN, a request to perform the conditional procedure related to the C-SN and the UE, the conditional procedure associated with a condition and a conditional configuration according to which the UE connects to the C-SN when the condition is satisfied; receiving, from the C-SN, a response to the request, the response including an SN-to-MN container; and retrieving the conditional configuration from the SN-to-MN container.

Abstract: Base stations perform methods for supporting a conditional procedure for a user equipment (UE). A method performed by a first base station may include receiving (1202), by the first base station from a second base station, an indication of one or more candidate secondary cells to which the UE can connect, subject to a condition, to communicate in dual connectivity (DC); receiving (1204), by the first base station, subsequently to the UE connecting to a secondary cell among the one or more candidate secondary cells for which the condition is satisfied, coordination information for the secondary cell, the coordinating information being usable for coordinating usage of radio resources with the second base station while the UE communicates in DC; and applying (1206), by the first base station, the coordination information to coordinate the usage of radio resources with the second base station.

Abstract: The disclosure provides a compressing structure for compressing a component, a power module and a method for compressing a component inside a chamber, the compressing structure is provided for compressing a component onto a fixed plate and comprises a plate-shaped structure, the component is secured to a first side of the plate-shaped structure, the outside of the plate-shaped structure is provided with a base; at least a steering compressing member is provided between a second side of the plate-shaped structure and the base, and mounted on the second side of the plate-shaped structure or the base, the steering compressing member is provided for transforming an rotational motion into a translational motion; and at least a positioning device mounted on the side of the plate-shaped structure and the base. The compressing structure provided by the disclosure compresses the component onto the fixed plate.

Abstract: A method, implemented by a distributed unit (DU) of a base station that also includes a central unit (CU), of handling small data transmission (SDT) with a user equipment (UE), includes receiving, from the UE while the CE is in an inactive state, a first message including uplink data (304). The uplink data includes control plane or non-control plane information. The method also includes determining, based on a logical channel with which the uplink data is associated, whether to transmit the uplink data to a control plane of the CU (CU-CP) or a user plane of the CU (CU-UP) (306), and transmitting the uplink data to cither the CU-CP (308) or the CU-UP (320) in accordance with the determining.

Abstract: Managing paging for Multicast and/or Broadcast Services (MBSs) of interested UEs that do not have an active radio connection with the RAN can include providing, in MBS service paging instructions, indications of respective radio capabilities of interested UEs in conjunction with the identifications of the interested UEs, e.g., so that DUs can have necessary UE radio capability information in-line with the paging instructions. Another technique can include a base station providing an indication of UE radio capability information of interested UEs to another base station. Still another technique includes storing, at a DU or at a CU, an indication of UE radio capabilities and/or a default or predetermined set of UE radio capabilities for use in paging interested UEs.

Abstract: A method in a distributed unit (DU) of a distributed base station for managing early data transmission includes receiving (2402), from a user equipment (UE) when the UE operates in an inactive state associated with a protocol for controlling radio resources, (i) data and (ii) a message formatted in accordance with the protocol. The method further includes transmitting (2404), to a central unit (CU) of the distributed base station, the message via a control plane interface, and transmitting (2406) the data to the CU.

Abstract: To process early data transmissions from a UE, a distributed unit (DU) of a base station transmits, by processing hardware, a preconfigured uplink resource (PUR) configuration to the UE in a release message that instructs the UE to transition to an inactive state (610). While the UE is in the inactive state, the DU receives, by the processing hardware from the UE, a data packet via a PUR resource configured in the PUR configuration (612).

Abstract: The disclosure provides a compressing structure for compressing a component, a power module and a method for compressing a component inside a chamber, the compressing structure is provided for compressing a component onto a fixed plate and comprises a plate-shaped structure, the component is secured to a first side of the plate-shaped structure, the outside of the plate-shaped structure is provided with a base; at least a steering compressing member is provided between a second side of the plate-shaped structure and the base, and mounted on the second side of the plate-shaped structure or the base, the steering compressing member is provided for transforming an rotational motion into a translational motion; and at least a positioning device mounted on the side of the plate-shaped structure and the base. The compressing structure provided by the disclosure compresses the component onto the fixed plate.

Abstract: The invention discloses a power module and a power conversion device. The power module includes a primary converting unit including a first active device unit; a secondary converting unit including a second active device unit; a transformer including a primary unit connected to the primary converting unit and a secondary unit connected to the secondary converting unit; a first heat dissipating unit on which the primary unit and the first active device unit are disposed; a second heat dissipating unit on which the secondary unit and the second active device unit are disposed; and an insulating plate including an insulating plate body and a semi-conducting layer disposed on a surface of the insulating plate body.

Abstract: A radio access network (RAN) for configuring a user equipment (UE) transmits, to the UE, (i) a conditional configuration related to a base station operating in the RAN, and (ii) a condition to be satisfied before the UE applies the conditional configuration during a conditional procedure (1802), determines subsequently to the transmitting, that the UE is to perform an immediate procedure related to the RAN (1804), and provides, to the UE, an indication that the UE is to release the conditional configuration (1806).

Abstract: A method of isolating at least one sphingolipid portion selected from a sphingoid base portion, a ceramide portion, a glycosphingolipid portion or a phosphosphingolipid portion from Cordyceps, in particular from wild-type Cordyceps, allows for obtaining sphingolipid portions having an increased amount of one of sphingoid bases, ceramides, glycosphingolipids or phosphosphingolipids. The sphingolipid portions isolated contained significant amounts of sphingolipids not reported so far, and possess exceptional immunosuppressive activities. A method of treating a subject suffering from an inflammatory disease like an autoimmune disease or an allergic disease includes administering sphingolipids isolated from Cordyceps, in particular from wild-type Cordyceps. A method of treating a subject suffering from an inflammatory disease includes administering certain sphingolipids to the subject.

Abstract: The invention discloses a power module and a power conversion device. The power module includes a primary converting unit including a first active device unit; a secondary converting unit including a second active device unit; a transformer including a primary unit connected to the primary converting unit and a secondary unit connected to the secondary converting unit; a first heat dissipating unit on which the primary unit and the first active device unit are disposed; a second heat dissipating unit on which the secondary unit and the second active device unit are disposed; and an insulating plate including an insulating plate body and a semi-conducting layer disposed on a surface of the insulating plate body.

Abstract: The present invention discloses a method of determining the presence of autoimmune disease with the use of glycan biomarkers. A method of improving the detection sensitivity of trace glycans from a mixture of glycans and a microfluidic chip therefor are also disclosed.

Abstract: The present invention provides a method of isolating at least one ingredient with anti-viral efficacy from Baphicacanthus cusia. The ingredient can be an alkaloid, a triterpenoid, a lignan, a phenylethanoid, a sesquiterpene lactone, or a flavonoid. Two new alkaloids are produced, which have not been previously reported. Moreover, the method isolates 12 compounds which could not or have not been previously isolated. A pharmaceutical composition includes the at least one ingredient and at least one pharmaceutical tolerable excipient. A method of treating a subject suffering from a viral disease includes administering at least one ingredient isolated from Baphicacanthus cusia.

Abstract: The present invention discloses a method of determining the presence of autoimmune disease with the use of glycan biomarkers. A method of improving the detection sensitivity of trace glycans from a mixture of glycans and a microfluidic chip therefor are also disclosed.

Abstract: A method of isolating at least one phenanthroindolizidine alkaloid, in particular with telomerase inhibitory activity, from Tylophora atrofolliculata is used to isolate and obtain for example about six to eight phenanthroindolizidine alkaloids, including at least four new phenanthroindolizidine alkaloids which have not been previously isolated. Experimental tests confirmed an exceptional telomerase inhibitory activity of the phenanthroindolizidine alkaloids isolated. A pharmaceutical composition includes at least one phenanthroindolizidine alkaloid and at least one pharmaceutical tolerable excipient. Still further, a method of treating a subject suffering from cancer includes administering at least one phenanthroindolizidine alkaloid isolated from Tylophora atrofolliculata. Also, a method of treating a subject suffering from cancer includes administering to the subject at least one phenanthroindolizidine alkaloid having certain formula.

Abstract: The present invention discloses a method of determining the presence of autoimmune disease with the use of glycan biomarkers. A method of improving the detection sensitivity of trace glycans from a mixture of glycans and a microfluidic chip therefor are also disclosed.

Abstract: A secondary base station (BS) for performing a modification procedure with a master BS comprises a storage device for storing instructions and a processing circuit coupled to the storage device. The storage device stores, and the processing circuit is configured to execute instructions of transmitting a first message comprising a first radio resource control (RRC) message and a secondary BS configuration to the master BS, wherein the secondary BS configuration comprises a plurality of configuration parameters; modifying the secondary BS configuration to a modified secondary BS configuration according to a master BS configuration, when receiving a second message comprising the master BS configuration from the master BS in response to the first message; and transmitting the modified secondary BS configuration to the master BS.

Abstract: A method of identifying and preferably quantifying at least one sphingolipid, in particular the sphingolipid portion in wild-type Cordyceps or Cordyceps derivates includes preparing a test sample solution from a Cordyceps sample, subjecting the test sample solution to liquid chromatrography with a mobile phase including at least a first and second eluting solvent; and performing a mass spectrometry after the step of subjecting. The quality and safety of Cordyceps products can be determined and wild-type Cordyceps and Cordyceps derivates may be differentiated via the ratio and/or presence of certain sphingolipids especially suitable as markers.

Abstract: A method of isolating at least one phenanthroindolizidine alkaloid, in particular with telomerase inhibitory activity, from Tylophora atrofolliculata is used to isolate and obtain for example about six to eight phenanthroindolizidine alkaloids, including at least four new phenanthroindolizidine alkaloids which have not been previously isolated. Experimental tests confirmed an exceptional telomerase inhibitory activity of the phenanthroindolizidine alkaloids isolated. A pharmaceutical composition includes at least one phenanthroindolizidine alkaloid and at least one pharmaceutical tolerable excipient. Still further, a method of treating a subject suffering from cancer includes administering at least one phenanthroindolizidine alkaloid isolated from Tylophora atrofolliculata. Also, a method of treating a subject suffering from cancer includes administering to the subject at least one phenanthroindolizidine alkaloid having certain formula.